Keywords: Forest Laboratories, Financial results, Third-quarter fiscal 2012/13

Forest Labs posts third-quarter loss, hit by Lexapro sales slump

Article | 16 January 2013

Print This

US drugmaker Forest Laboratories (NYE: FRX) saw its shares fall 5.6% to $35.39 in pre-market trading yesterday, when the company reported a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in